The clinical impact of mutant DNMT3A R882 variant allele frequency in acute myeloid leukaemia by Linch, DC, Hills, RK, Burnett, AK, Gale, RE

Analysis of the clinical impact of NPM1 mutant allele burden in a large cohort of younger adult patients with acute myeloid leukaemia by Linch, DC, Hills, RK, Burnett, AK, Russell, N, Gale, RE

A randomized assessment of adding the kinase inhibitor lestaurtinib to first-line chemotherapy for FLT3-mutated AML by Knapper, S, Russell, N, Gilkes, A, Hills, RK, Gale, RE, Cavenagh, JD, Jones, G, Kjeldsen, L, Grunwald, MR, Thomas, I, Konig, H, Levis, MJ, Burnett, AK